23Nov 2024
Anakinra Reduces Inflammation in Kidney Perfusion

Anakinra Reduces Inflammation in Kidney Perfusion

A study investigating the effects of anakinra, an interleukin-1 (IL-1) receptor antagonist, during normothermic machine perfusion (NMP) of porcine kidneys showed promising results in reducing inflammation. In the experiment, kidneys subjected to ischemia and cold storage were perfused with autologous blood and treated with either anakinra or a vehicle control. While there were no significant differences in kidney function parameters such as blood flow, urine output, or creatinine clearance, anakinra treatment significantly reduced the expression of inflammatory markers, including IL-6, Fas ligand, and intercellular adhesion molecule 1 (ICAM-1). These findings suggest that anakinra may help attenuate immune and inflammatory responses in renal transplant settings, potentially improving graft outcomes.

  • #neurology

Like

Save

Share